Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Healionics, a provider of tissue regeneration and device biointegration solutions to healthcare manufacturers, has raised $1.7 million in a series A financing.
Subscribe to our email newsletter
The financing was led by individual investors including Carl Lombardi, former CEO of SpaceLabs Medical and Sam Naficy, medical director of Naficy Plastic Surgery & Rejuvenation Center. The company intends to use the funds for expanding the potential of STAR (sphere templated angiogenic regenerative material) to enhance current and next generation medical devices.
Healionics’s propriety STAR is specifically engineered to enhance biointegration and promote healing. STAR is said to be designed to enable the biocompatibility of a wide range of medical devices that are implanted into the body.
Rob Brown, CEO of Healionics, said: “These funds will be used specifically to scale up the STAR material manufacturing process, to expand and accelerate preclinical studies of STAR materials and to advance our business development activities.”